New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Abbott Laboratories
ABT
Shape
US Flag

NYSE

199B

Medical - Devices

Next Earning date - 22 Jan 2025

199B

Medical - Devices

Next Earning date - 22 Jan 2025

114.22USD
Shape-2.32 ( -1.99%)
favorite-chart

Relative Strenght

13
favorite-chart

Volume Buzz

10%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

6%

Quote Panel

Shape
Updated October 27, 2024
1W -2.37 % 1M 0.65 % 3M 9.53 % 1Y 25.27 %

Key Metrics

Shape
  • Market Cap

    198.73B


  • Shares Outstanding

    1.74B


  • Share in Float

    1.73B


  • Dividende

    2.2


  • Earning Date

    22 Jan 2025


  • Price Target

    114.22


  • Average Volume

    5.43M


  • Beta

    0.722


  • Range

    91.64-121.64


  • Industry

    Medical - Devices


  • Website

    https://www.abbott.com


  • Sector

    Healthcare


Fundamentals

Shape

25.27x

P/E Ratio

4.82x

P/S Ratio

0.00x

P/B Ratio

0.0

Debt/Equity

14.0%

Net Margin

$3.3

EPS

How ABT compares to sector?

P/E Ratio

Relative Strength

Shape

ABT

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$45B

Shape323%

2025-Revenue

$3.94

Shape320%

2025-EPS

$11B

Shape450%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Piper Sandler

initialise

Previous: Buy

2024-10-16

Now: Overweight

Hovde Group

initialise

Previous: Not converted

2024-10-08

Now: Outperform

Susquehanna

initialise

Previous: Not converted

2024-10-08

Now: Positive

Oppenheimer

initialise

Previous: Not converted

2024-10-08

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-22%

1.03
vs 1.32

Q1.23

arrow
arrow

-40%

1.03
vs 1.73

Q2.23

arrow
arrow

-24%

1.08
vs 1.43

Q3.23

arrow
arrow

-1%

1.14
vs 1.15

Q4.23

arrow
arrow

+16%

1.19
vs 1.03

Q1.24

arrow
arrow

-5%

0.98
vs 1.03

Q2.24

arrow
arrow

+6%

1.14
vs 1.08

Q3.24

arrow
arrow

+6%

1.21
vs 1.14

Q4.24

arrow
arrow

+13%

1.34
vs 1.19

Q1.25

arrow
arrow

+14%

1.11
vs 0.98

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-12%

10.1B  vs 11.5B

Q1.23

arrow
arrow

-18%

9.7B  vs 11.9B

Q2.23

arrow
arrow

-11%

10B  vs 11.3B

Q3.23

arrow
arrow

-3%

10.1B  vs 10.4B

Q4.23

arrow
arrow

+1%

10.2B  vs 10.1B

Q1.24

arrow
arrow

+2%

10B  vs 9.7B

Q2.24

arrow
arrow

+4%

10.4B  vs 10B

Q3.24

arrow
arrow

+5%

10.6B  vs 10.1B

Q4.24

arrow
arrow

+8%

11B  vs 10.2B

Q1.25

arrow
arrow

+7%

10.7B  vs 10B

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

+3%

0.03
vs 0.04

Q1.23

arrow
arrow

+2%

0.02
vs 0.03

Q2.23

arrow
arrow

+4%

0.04
vs 0.02

Q3.23

arrow
arrow

+4%

0.04
vs 0.04

Q4.23

arrow
arrow

+4%

0.04
vs 0.04

Q1.24

arrow
arrow

+3%

0.03
vs 0.04

Q2.24

arrow
arrow

+3%

0.03
vs 0.03

Q3.24

arrow
arrow

NA

NA
vs 0.03

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

2672

2.7K
vs 2.7K

-2%

Q4.22

arrow
arrow

2818

2.8K
vs 2.7K

5%

Q1.23

arrow
arrow

2747

2.7K
vs 2.8K

-3%

Q2.23

arrow
arrow

2775

2.8K
vs 2.7K

1%

Q3.23

arrow
arrow

2724

2.7K
vs 2.8K

-2%

Q4.23

arrow
arrow

2921

2.9K
vs 2.7K

7%

Q1.24

arrow
arrow

2939

2.9K
vs 2.9K

1%

Q2.24

arrow
arrow

2835

2.8K
vs 2.9K

-4%

Earnings Growth

Latest News